{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Meningococcal Disease Vaccines - Who's at Risk and the Future

Purpose of Activity

To provide information on meningococcal disease and meningococcal vaccines.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Outline issues related to meningococcal disease.
  2. Compare the clinical applications of conjugate and serogroup B (MenB) meningococcal vaccines.
Price: $17.95


  • ANCC 1.5 CH / 1.0 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: CNS0118
Published: Jan/Feb 2018
Expires: 12/6/2019
Passing Score: 14/19 (73%)
Authors: Patricia Anne O'Malley, PhD, RN, CNS